Hepatocellular carcinoma cost-effectiveness of therapy
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Hepatocellular carcinoma (HCC) most commonly appears in a patient with chronic viral hepatitis (hepatitis B or hepatitis C, 20%) or with cirrhosis (about 80%). These patients commonly undergo surveillance with ultrasound due to the cost-effectiveness.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
